SCHEMBL1492574

SCHEMBL1492574

CSc1ccc(N)cn1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29922639 1.00
SCHEMBL15164845 0.82 CA12 (0.41)
SCHEMBL7673327 0.80 CA12 (0.46)
SCHEMBL5387999 0.80 CA2 (0.52)
SCHEMBL18757941 0.76
SCHEMBL24502974 0.76 CA12 (0.39)
SCHEMBL20749977 0.76 CA12 (0.39)
SCHEMBL1492564 0.76 PIK3CD (0.47)
SCHEMBL23634053 0.74 CA12 (0.42)
SCHEMBL485398 0.73

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 68 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2300472-B1 GLUCOCORTICOID MIMETICS, METHODS OF MAKING THEM, PHARMACEUTICAL COMPOSITIONS, AND USES THEREOF BOEHRINGER INGELHEIM INT (DE) 2012-01-18 EP claimed
JP-2011524867-A 2011-09-08 JP claimed
EP-2300472-A1 GLUCOCORTICOID MIMETICS, METHODS OF MAKING THEM, PHARMACEUTICAL COMPOSITIONS, AND USES THEREOF Boehringer Ingelheim International GmbH (DE) 2011-03-30 EP claimed
US-7683097-B2 Topoisomerase inhibitors Propharmacon Inc. (US) 2010-03-23 US claimed
US-20090325988-A1 Glucocorticoid Mimetics, Methods of Making Them, Pharmaceutical Compositions and Uses Thereof BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) 2009-12-31 US claimed
WO-2009149139-A1 GLUCOCORTICOID MIMETICS, METHODS OF MAKING THEM, PHARMACEUTICAL COMPOSITIONS, AND USES THEREOF BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2009-12-10 WO claimed
US-12441707-B2 Indazole compounds TYRA BIOSCIENCES, INC. (US) 2025-10-14 US disclosed
CN-117813302-A Substituted tetrahydrofuran-2-carboxamides as sodium channel modulators 沃泰克斯药物股份有限公司 2024-04-02 CN disclosed
US-20230115528-A1 INDAZOLE COMPOUNDS TYRA BIOSCIENCES, INC. 2023-04-13 US disclosed
CN-110818641-B Pyridazine-3-formamide compound, preparation method and application thereof in medicine and pharmacology 北京诺诚健华医药科技有限公司 2022-10-14 CN disclosed
WO-2021138391-A1 INDAZOLE COMPOUNDS TYRA BIOSCIENCES, INC. (US) 2021-07-08 WO disclosed
US-10806726-B2 Methods of using indazole-3-carb oxamides and their use as Wnt/B-catenin signaling pathway inhibitors SAMUMED, LLC (US) 2020-10-20 US disclosed
CN-110818641-A Pyridazine-3-formamide compound, preparation method and application thereof in medicine and pharmacology 北京诺诚健华医药科技有限公司 2020-02-21 CN disclosed
WO-2006022955-A2 TOPOISOMERASE INHIBITORS PROPHARMACON, INC. (US) 2006-03-02 WO disclosed
EP-1278723-B1 P-(SULFONYL)-ARYL AND -HETEROARYL AMINES HOFFMANN LA ROCHE (CH) 2005-08-31 EP disclosed
US-20050070562-A1 Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto ARENA PHARMACEUTICALS, INC. 2005-03-31 US disclosed
EP-1278723-A2 P-(SULFONYL)-ARYL AND -HETEROARYL AMINES F. HOFFMANN-LA ROCHE AG (CH) 2003-01-29 EP disclosed
US-20020052349-A1 p-(sulfonyl) aryl and heteroarylamines as anti-inflammatory agents SYNTEX (U.S.A.) LLC 2002-05-02 US disclosed
WO-2001083434-A2 P-(SULFONYL)-ARYL AND HETEROARYLS AMINES F. HOFFMANN-LA ROCHE AG (CH) 2001-11-08 WO disclosed
US-4001254-A ISOTHIOCYANOPYRIDINE DERIVATIVES CIBA-GEIGY CORPORATION (US) 1977-01-04 US disclosed